Eyegate (EYEG) Surges on New 'Buy' Rating
Tweet
Share
E-mailGet Alerts EYEG Hot Sheet
Price: $34.31 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Join SI Premium – FREE
Eyegate Pharmaceuticals (NASDAQ: EYEG) is surging 66% in early trade after Rodman & Renshaw initiated coverage on with a Buy rating and a price target of $10.00.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
- Canaccord Starts CareDx, Inc (CDNA) at Buy
- Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
Create E-mail Alert Related Categories
Hot New Coverage, Momentum Movers, New Coverage, Trader TalkRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
